News
HQL
13.10
-0.38%
-0.05
Weekly Report: what happened at HQL last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at HQL last week (0408-0412)?
Weekly Report · 04/15 09:22
Weekly Report: what happened at HQL last week (0401-0405)?
Weekly Report · 04/08 09:24
Weekly Report: what happened at HQL last week (0325-0329)?
Weekly Report · 04/01 09:23
Weekly Report: what happened at HQL last week (0318-0322)?
Weekly Report · 03/25 09:24
Weekly Report: what happened at HQL last week (0311-0315)?
Weekly Report · 03/18 09:24
Weekly Report: what happened at HQL last week (0304-0308)?
Weekly Report · 03/11 09:23
Weekly Report: what happened at HQL last week (0226-0301)?
Weekly Report · 03/04 09:24
Weekly Report: what happened at HQL last week (0219-0223)?
Weekly Report · 02/26 09:26
The abrdn Healthcare Opportunities Fund Is Due For A Breakout
Seeking Alpha · 02/20 16:00
Weekly Report: what happened at HQL last week (0212-0216)?
Weekly Report · 02/19 09:27
Weekly Report: what happened at HQL last week (0205-0209)?
Weekly Report · 02/12 09:24
abrdn Life Sciences Investors raises dividend by 30% to $0.39
Abrdn Life Sciences Investors raises dividend by 30% to $0.39. Forward yield 11.26% Payable March 28; for shareholders of record Feb. 22; ex-div Feb. 21. The company intends to maintain the increased Managed Distribution Policy for the next year.
Seeking Alpha · 02/12 07:30
Weekly Report: what happened at HQL last week (0129-0202)?
Weekly Report · 02/05 09:26
Weekly Report: what happened at HQL last week (0122-0126)?
Weekly Report · 01/29 09:24
Weekly Report: what happened at HQL last week (0115-0119)?
Weekly Report · 01/22 09:25
Weekly Report: what happened at HQL last week (0108-0112)?
Weekly Report · 01/15 09:24
abrdn Life Sciences Investors: [Amend]General statement of acquisition of beneficial ownership
Press release · 01/12 18:14
The Month In Closed-End Funds: December 2023
For the second consecutive month, both equity and fixed income CEFs on average posted plus-side returns. 93% of all closed-end funds posted net-asset-value returns in the black for December. At month end, 9% of CEFs traded at a premium to their NAV. The median discount of all CEFs widened 28 bps to 11.97% in December.
Seeking Alpha · 01/10 23:30
Weekly Report: what happened at HQL last week (0101-0105)?
Weekly Report · 01/08 09:25
More
Webull provides a variety of real-time HQL stock news. You can receive the latest news about abrdn Life Sciences Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQL
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.